GNH USA

Europe — EMA

Moxonidine Teva

GNH USA supplies Moxonidine Teva (Moxonidine), an imidazoline receptor agonist for hypertension. Request a quote for worldwide supply to hospitals.

Moxonidine

Request sourcing

1
Pack/s

What is Moxonidine?

Moxonidine, the active ingredient in Moxonidine Teva, is an imidazoline receptor agonist presented as an oral tablet for systemic use. It selectively lowers elevated blood pressure by reducing sympathetic nervous system activity and is indicated for the treatment of hypertension in adult patients.

GNH USA supplies Moxonidine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, including temperature‑controlled shipping where required.

What is Moxonidine used for?

Moxonidine is used in the management of elevated arterial pressure by stimulating central imidazoline I1 receptors, which leads to reduced sympathetic outflow.

Hypertension: lowers both systolic and diastolic blood pressure, helping achieve guideline‑recommended targets in adult patients. Essential hypertension: provides effective blood pressure control as monotherapy or in combination with other antihypertensives. Resistant hypertension (adjunct): may be added when blood pressure remains uncontrolled despite use of at least three antihypertensive agents.

What are the side effects of Moxonidine?

Moxonidine may be associated with a range of adverse reactions, which are generally classified by frequency.

Common Side Effects: - Dry mouth: sensation of oral dryness. - Dizziness: light‑headedness, especially on standing. - Fatigue: feeling of tiredness or reduced energy. - Headache: mild to moderate cranial pain. - Nausea: upset stomach, occasional vomiting.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing fainting. - Bradycardia: abnormally low heart rate requiring medical attention. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

What precautions apply to Moxonidine?

When prescribing Moxonidine, clinicians should consider several precautionary measures to ensure safe use.

Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension. Renal impairment: dose adjustment may be required in patients with reduced kidney function. Hepatic disease: use cautiously and monitor liver function tests. Elderly patients: start at lower dose due to increased sensitivity. Concomitant antihypertensives: assess risk of additive blood pressure lowering. Store at room temperature: keep in original packaging, protect from moisture and heat.

What does Moxonidine interact with?

Moxonidine can interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid): - Combined use with other central sympatholytics (e.g., clonidine) may cause profound hypotension. - Concurrent administration with potent CYP2D6 inhibitors can increase plasma levels, raising risk of adverse effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: additive effect on heart rate and blood pressure, monitor vitals. - Diuretics: may enhance antihypertensive effect, adjust dose as needed. - NSAIDs: can attenuate antihypertensive response, observe blood pressure control.

Frequently asked questions

What is Moxonidine Teva used for?+
Moxonidine Teva is prescribed for the treatment of hypertension. By reducing sympathetic nervous system activity, it helps lower both systolic and diastolic blood pressure, supporting patients in reaching recommended blood‑pressure targets.
How does Moxonidine work?+
Moxonidine selectively stimulates central imidazoline I1 receptors in the brainstem. This activation dampens sympathetic outflow, leading to decreased peripheral vascular resistance, lower heart rate, and reduced renin release, which together lower arterial blood pressure.
What is the usual dose of Moxonidine Teva?+
The exact dose of Moxonidine Teva is determined by the prescribing clinician based on the individual’s blood‑pressure profile, age, renal function and concomitant therapies. Typically, treatment starts at a low dose and is titrated to achieve optimal control.
Is Moxonidine safe during pregnancy or breastfeeding?+
Safety data for Moxonidine in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It is generally recommended to avoid use unless the potential benefit justifies the potential risk to the fetus or infant.
How do I order Moxonidine Teva from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Moxonidine compare with other antihypertensive drugs?+
Moxonidine differs from traditional agents such as ACE inhibitors or beta‑blockers by targeting central imidazoline I1 receptors rather than the renin‑angiotensin system or adrenergic receptors. This mechanism can result in fewer metabolic side effects, but clinicians still consider individual patient profiles when choosing therapy.
How should Moxonidine be stored?+
Moxonidine tablets should be stored at room temperature, below 25 °C, in the original container. Protect them from moisture, direct sunlight and excessive heat to maintain product stability throughout its shelf life.
How is Moxonidine administered?+
Moxonidine is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescriber’s instructions regarding timing and whether the dose should be taken in the morning or evening.
What are the most serious risks associated with Moxonidine?+
The most serious adverse events to monitor are severe hypotension, which can cause fainting, and bradycardia, an abnormally low heart rate. Hepatic dysfunction and severe allergic reactions, including anaphylaxis, are also rare but require immediate medical attention.
Who should not use Moxonidine?+
Moxonidine is contraindicated in patients with known hypersensitivity to the drug, those with severe hypotension, and individuals with certain cardiac conduction disorders. Caution is also advised for patients with significant renal or hepatic impairment, and it should be avoided in pregnancy unless absolutely necessary.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Moxonidine
Route
Oral Use
Manufacturer
Teva B.V
Origin
EU

Related products

Cynt

Cynt

Moxonidine

Viatris Hrvatska D.O.O.
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Biomin, A.S.
EU